Cookies

Like most websites The Translational Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Outside the Lab Cancer, Diagnostics & prognostics, Public health

Does Screening Save Lives?

The UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) is one of the largest clinical trials ever conducted worldwide – 202,000 women in 13 regions across the UK are involved. The study estimates a 15–28 percent reduction in mortality attributable to ovarian cancer screening via annual blood tests for CA125 (1), but many have reacted with caution at this stage. We spoke with lead author Ian Jacobs, professor at University College London’s Department of Women's Cancer, to find out more.

Enjoy our FREE content!

Log in or register to read this article in full and gain access to The Translational Scientist’s entire content archive. It’s FREE and always will be!

Login if you already created an account

Or register now - it’s free and always will be!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
Register

Or Login as a Guest or via Social Media

Newsletter

Send me the latest from The Translational Scientist.

Sign up now

Most Popular

Register here

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register